For example, Debruyne et al. reported an activation of BORIS expression in anaplastic lymphoma kinase (ALK)-mutated, MYCN-amplified neuroblastoma cells that develop resistance to ALK inhibition [21]. The gene discussed is ALK; the disease is neuroblastoma.